Diagnostics

PMD Device Solutions Signs Transfer Agreement for Key Assets in Coala-Life Group AB to Accelerate its US Market Entry

STOCKHOLM, SWEDEN / ACCESSWIRE / April 11, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) ("PMDS") today announced it has signed a…

7 months ago

iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium

ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering radiologists in…

8 months ago

Digostics and AgaMatrix Partner to Introduce Oral Glucose Tolerance Home Testing for UK Expectant Mothers

Digostics and AgaMatrix Team Up to Improve Gestational Diabetes Screening for UK Women via the Introduction of Oral Glucose Tolerance…

8 months ago

My Quest Story – Jessica Clow

NORTHAMPTON, MA / ACCESSWIRE / April 9, 2024 / Quest Diagnostics:I began working at Quest Diagnostics in December 2020. Having…

8 months ago

Gemina Labs Announces Addition to its IP Portfolio

VANCOUVER, BC / ACCESSWIRE /April 9, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") today announces that it…

8 months ago

Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan

Exponential Health, an innovative concierge medicine practice in Michigan, adopts Cardio Diagnostics' AI-driven epigenetic-genetic tests, marking a new era in…

8 months ago

GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its first quarter 2024 financial results before…

8 months ago

Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024

ANN ARBOR, MI / ACCESSWIRE / April 9, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

8 months ago

Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”

Panel of renowned cardiologists, all globally recognized experts in heart failure, will discuss the unmet medical need in pulmonary hypertension…

8 months ago

Mainz Biomed Reports Full Year 2023 Financial Results

ColoAlert® Revenue Increased 69% Year Over Year; Net Loss in Line with Previous Year; Cash Balance at Year End of…

8 months ago